This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The biopharmaceutical industry remained resilient in the second quarter (Q2) of 2024 as global markets and investor optimism improved with anticipation of a potential interest rate cut from the US Federal Reserve. trillion as on 31 March 2024 to $4 trillion as on 30 June 2024, reveals GlobalData.
Adults with underlying medical conditions, such as chronic obstructive pulmonary disease (COPD), asthma, heart failure and diabetes (3) are at increased risk for severe consequences from an RSV infection compared to those without these conditions. RSV can exacerbate these conditions and lead to pneumonia, hospitalisation or death.(4)
Ophelia Chan, Business Fundamentals Senior Analyst at GlobalData, comments, “The COVID-19 pandemic highlighted the key advantages of mRNA technology in vaccine development, including rapid production, precise immune targeting, and streamlined manufacturing- factors that drove the success of mRNA-based COVID-19 vaccines.” billion in July 2024.
I am hoping to feel more settled in 2024. I am wrapping up some projects in early 2024 and I am carving out more time for myself and my own healing. Adaptogens may also be anti-inflammatory, neuroprotective, and supportive of a healthy immune function. Does Adrenal Fatigue Exist? Gut Recovery Program (est.
Jeff Todd , President & Chief Executive Officer of Prevent Blindness, was named the Chair of the NHC Board of Directors for 2024. Jeff Todd , President & Chief Executive Officer of Prevent Blindness, was named the Chair of the NHC Board of Directors for 2024.
This month, new data from Novo Nordisk has revealed that semaglutide could become the first GLP-1 treatment option for patients with type 2 diabetes and chronic kidney disease (CKD). This leads to the formation of immune complexes that deposit in the glomerulus and result in haematuria, proteinuria, and decline in kidney function.
This month, new data from Novo Nordisk has revealed that semaglutide could become the first GLP-1 treatment option for patients with type 2 diabetes and chronic kidney disease (CKD). This leads to the formation of immune complexes that deposit in the glomerulus and result in haematuria, proteinuria, and decline in kidney function.
While this approach has shown to be safe and efficient in Clostridium difficile, the variability between donors may lead to random outcomes and responses in patients for immune-mediated diseases. Notably, from one donor to another, significant variations exist. Internet] Pharmaceutical Technology. cited 2024Feb]. cited 2024Feb].
During the meeting, new and reelected members of 2024 National Health Council Board of Directors as well as the 2024 Executive Committee were announced. We will see you in 2024! He ended his talk on the power of AI and LLMs in decision-making and how AI can benefit the patient experience.
2 These are cells commonly found in the stroma of the tumour, which play an important role in inhibiting the body’s own immune response to the tumour, mediated through CD8+ T-cells (tumour-infiltrating lymphocytes). This includes Glucox Biotech’s GLX7013114, which inhibits NOX4 and is in development for diabetic retinopathy.
Guest Blog: Climate change and its impact on Autoimmune Disease October 24, 2024 By: Olivia Casey, Sr. Autoimmune and immune-mediated diseases occur when the body’s immune system works abnormally or attacks itself. Chronic exposure to unsafe levels is tied to a 10% increase in developing a variety of immune-mediated diseases.
With additional firepower, the pharma companies are looking to acquire innovative technologies specifically in precision medicine, cell and gene therapy, cancer and rare diseases, diabetes, auto-immune diseases, and weight loss which will hurl additional M&A activity.
With additional firepower, the pharma companies are looking to acquire innovative technologies specifically in precision medicine, cell and gene therapy, cancer and rare diseases, diabetes, auto-immune diseases, and weight loss which will hurl additional M&A activity.
He is a type 2 diabetic and is not always compliant with his medications. She has a family history of hypertension and diabetes. He has a history of hypertension, type 2 diabetes mellitus, hyperlipidemia, and congestive heart failure. We’re giving you just a taste of what you might expect on your actual board exam.
Company: AstraZeneca First Approval Date: Jul 31, 2009 Generic Name: Saxagliptin Patent Expiration: Jan 2023 2022 Sales: $257M Indication: Type 2 Diabetes Mellitus Onglyza is a member of the dipeptidyl peptidase-4 inhibitor class of oral hypoglycemics used combined with diet and exercise for managing type 2 diabetes.
Diabetic Neuropathy Diabetic neuropathy, a common complication of long-term high blood sugar and insulin resistance, can cause constipation. 40] Additionally, some diabetes medications can contribute to this issue. 88] This can be particularly beneficial in managing slow digestion often seen in diabetic gastroparesis.
Through its internal development, partnerships, and acquisitions, the company has put together four technology platforms that primarily focus on antibodies, T cells, innate immunity, and siRNAs. Currently, AstraZeneca is conducting a P-I clinical trial for the evaluation of ALXN2030 in healthy individuals with data anticipated in 2024.
Guest Blog: The Unique Challenges of Type 1 Diabetes in Women: A Patient Perspective November 14, 2024 By: Syreen Goulmamine, MPH, Science Programs Manager at the Society for Women’s Health Research Autoimmune diseases occur when the body’s immune system mistakenly attacks its own healthy cells thinking they are germs or foreign bodies.
The Unique Challenges of Type 1 Diabetes in Women: A Patient Perspective November 14, 2024 By: Syreen Goulmamine, MPH, Science Programs Manager at the Society for Women’s Health Research Autoimmune diseases occur when the body’s immune system mistakenly attacks its own healthy cells thinking they are germs or foreign bodies.
Vidofludimus calcium (IMU-838), a drug developed by Immunic Therapeutics, is a prime example of this. Although effective, this approach often results in significant side effects, including increased susceptibility to viral reactivation, infections, and, in some cases, a heightened risk of cancer due to reduced immune surveillance.
I subsequently learned that the risk of having carpal tunnel increases during pregnancy as well as in people with hypothyroidism, rheumatoid arthritis, diabetes, obesity, and other inflammatory and metabolic health conditions. I know so many people who have had surgery for carpal tunnel syndrome, but I was hoping to avoid surgery if I could.
1 Cells can be delivered to a specific location in a scaffold that protects them from immune attack while allowing diffusion of cytokines out of the scaffold, also enabling the slow release of the cells into the region. 2 It must be injectable into small areas such as joints, should not induce pain, and its breakdown components must be safe.
There is a known link between Hashimoto’s and type 2 diabetes, with up to 30 percent of those with Hashimoto’s developing the condition. Conversely, patients with type 2 diabetes are at an increased risk of developing a thyroid disorder, especially women. Ozempic is a recent blockbuster drug with benefits for diabetes and weight.
We organize all of the trending information in your field so you don't have to. Join 11,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content